We are live on
!
Find out more
Aurinia Pharmaceuticals
AUPH
AUPH
190 hedge funds and large institutions have $892M invested in Aurinia Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
104% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 26
63% more call options, than puts
Call options by funds: $201M | Put options by funds: $123M
14% more funds holding
Funds holding: 166 → 190 (+24)
7% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 55
3.96% less ownership
Funds ownership: 34.09% → 30.14% (-4%)
8% less capital invested
Capital invested by funds: $965M → $892M (-$72.5M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
190
Holders Change
+24
Holders Change %
+14.46%
% of All Funds
2.92%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
53
Increased
59
Reduced
55
Closed
26
Calls
$201M
Puts
$123M
Net Calls
+$77.6M
Net Calls Change
+$70M
Top Buyers
| 1 |
BlackRock
New York
|
+$21.8M |
| 2 |
MAM
Melqart Asset Management
London,
United Kingdom
|
+$21.7M |
| 3 |
Citigroup
New York
|
+$18M |
| 4 |
N
Natixis
Paris,
France
|
+$11.8M |
| 5 |
Renaissance Technologies
New York
|
+$11.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$85.5M |
| 2 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$49.8M |
| 3 |
Morgan Stanley
New York
|
-$46.2M |
| 4 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
-$17.7M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$11.5M |
